Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Randall J. Mack"'
Autor:
Neil Singla, MD, Matthew Bindewald, MD, Sonia Singla, DO, David Leiman, MD, Harold Minkowitz, MD, Stewart W. McCallum, MD, Randall J. Mack, BS, Rosemary Keller, PhD, CRNP, Alex Freyer, PharmD, Wei Du, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 6, p e1846 (2018)
Background:. A nanocrystal intravenous (IV) formulation of meloxicam is being studied with the aim of providing postoperative analgesia. Methods:. This randomized, multicenter, double-blind, placebo-controlled trial evaluated meloxicam IV 30 mg or pl
Externí odkaz:
https://doaj.org/article/5df992a1935b46138678c83cfeb09ac4
Autor:
Jonathan S. Jahr, Alex Freyer, Stewart W. McCallum, Randall J Mack, Sue Hobson, Wei Du, Shawn Searle, Kim Minger
Publikováno v:
Clinical pharmacology in drug development, vol 9, iss 7
Clinical Pharmacology in Drug Development
Clinical Pharmacology in Drug Development
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are effective treatments for pain but may induce bleeding events due to platelet dysfunction associated with inhibition of cyclooxygenase (COX)‐1 impairing thromboxane production. An intravenous nanoc
Autor:
Stewart W. McCallum, Kipling P Sharpe, Randall J Mack, Richard D Berkowitz, William A Tyndall, David Boyer, Wei Du
Publikováno v:
Journal of Pain Research. 13:221-229
Objective A Phase 3 randomized multicenter, double-blind, placebo-controlled trial (NCT02720692) compared once-daily intravenous (IV) meloxicam 30 mg to placebo, when added to the standard of care pain management regimens, in adults with moderate-to-
Autor:
Neil Singla, Randall J Mack, Stewart W. McCallum, Tong J. Gan, Sue Hobson, Eugene R. Viscusi, Wei Du, Sergio D. Bergese
Publikováno v:
Regional Anesthesia & Pain Medicine. 44:360-368
Background and objectivesTo describe the safety and tolerability of intravenous meloxicam compared with placebo across all phase II/III clinical trials.MethodsSafety data and opioid use from subjects with moderate to severe postoperative pain who rec
Autor:
Richard D Berkowitz, Richard Steinfeld, Erin Coyle, Wei Du, Alex Freyer, Alexander P. Sah, Libby Black, Randall J Mack, Stewart W. McCallum
Publikováno v:
Pain Medicine: The Official Journal of the American Academy of Pain Medicine
ObjectiveTo evaluate the effect of perioperative meloxicam IV 30 mg on opioid consumption in primary total knee arthroplasty (TKA).DesignMulticenter, randomized, double-blind, placebo-controlled trial.SubjectsIn total, 181 adults undergoing elective
Publikováno v:
Pain management. 11(3)
Meloxicam for intravenous use (meloxicam iv.) is a nanocrystal formulation with improved dissolution properties and shortened time to peak plasma concentrations versus oral meloxicam. In Phase III and IIIb trials, 30 mg once daily relieved pain follo
Autor:
Libby Black, Wei Du, Stewart W. McCallum, Alex Freyer, Jorge E. Marcet, Swapna U. Karkare, Randall J Mack, Vamshi Ruthwik Anupindi, Drishti Shah, Jennifer D. Silinsky
Publikováno v:
Pain management. 11(1)
Aim: Evaluate safety/efficacy of intravenous meloxicam in a colorectal enhanced recovery after surgery protocol. Methods: Adults undergoing primary open or laparoscopic colorectal surgery with bowel resection and/or anastomosis received meloxicam IV
Autor:
Campbell P Howard, Alex Freyer, Randall J Mack, Wei Du, Stewart W. McCallum, Deborah R Tunick, Ira J. Gottlieb
Publikováno v:
Journal of Pain Research
Objective This randomized, double-blind, placebo-controlled study evaluated the safety and efficacy of an intravenous (IV) nanocrystal formulation of meloxicam in subjects with moderate-to-severe pain following a standardized unilateral bunionectomy.
Publikováno v:
Anesthesia and Analgesia
BACKGROUND: An intravenous (IV) formulation of meloxicam was developed for moderate-to-severe pain management. This study evaluated the safety and efficacy of meloxicam IV after open abdominal hysterectomy. Meloxicam IV is an investigational product
Autor:
Stewart W. McCallum, Randall J Mack, Swapna U. Karkare, Vamshi Ruthwik Anupindi, Teresa Galas, Libby Black, Wei Du, Conor P. Delaney, Jennifer D. Silinsky, Alex Freyer, Drishti Shah
Publikováno v:
Gastroenterology. 158:S-1512